Fingerprint
Dive into the research topics of 'Inotuzumab ozogamicin, a nonchemotherapy option for relapsed acute lymphoblastic leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Inotuzumab ozogamicin, a nonchemotherapy option for relapsed acute lymphoblastic leukemia
Research output: Contribution to journal › Article › peer-review